The Latest Breaking News from Aetna

Beneficiaries enrolled in Medicare Advantage and Part D prescription drug plans might be losing their plan as UnitedHealthcare, Humana, and Aetna (CVS Health) scale back offerings for 2026.

Aetna, a CVS Health Inc. (NYSE:CVS) company, announced it will scale the Aetna Clinical Collaboration (ACC) program to ten hospitals by year-end, with implementations underway with AdventHealth Shawnee Mission, Houston Methodist, and WakeMed Health Hospitals.

Healthcare stocks took a tumble in 2024 as rising medical costs did a number on margins and profitability, but 2025 may be the year they rebound.

CVS stock has surged 45% in 2025, driven by strong Q4 earnings, a new CEO, and strategic innovations.

An integrated healthcare model sees healthcare providers merge with health insurers. While CVS Health proves it can't be done, UnitedHealth may prove it can.

Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic conditions that afflict millions of Americans. But while everyone agrees these drugs have the potential to transform lives, no one can agree on how best to pay for them.

Employees should be free to choose their own health care plans, but be given the same contributions from their workplaces, Mark Bertolini argued.

Curbing agents’ commissions may hurt beneficiaries.

CVS and Walgreens shares have plummeted from all the M&A, while Rite Aid is a much smaller chain.